Pharmaceutical

AGFA HealthCare Empowers Future Tech Leaders Through Immersive Hands-on STEM Day for Girls in Orlando With Powerteens

"Girls in Focus: A One-Day STEM Experience" introduces middle and high school girls to real-world careers in healthcare technology ORLANDO,…

4 months ago

Relief Therapeutics Publishes 2025 Half-Year Report

GENEVAD, SE / ACCESS Newswire / August 14, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company),…

4 months ago

Illinois Review Board Approves Hillsboro Health Certificate of Need Application

Hospital Construction Project Will Provide Infrastructure Modernization HILLSBORO, ILLINOIS / ACCESS Newswire / August 13, 2025 / The Illinois Health…

4 months ago

Global Digital Therapeutics Market Experiencing Rapid Growth at a CAGR of ~28% by 2032 Amid Rising Demand for Personalized Healthcare| DelveInsight

The digital therapeutics market is experiencing rapid growth, driven by rising demand for personalized, evidence-based digital health interventions. Increasing prevalence…

4 months ago

InstantGMP™ Announces Major Enhancements to GMP Certification Resource Center

CARY, N.C., Aug. 13, 2025 /PRNewswire/ -- InstantGMP™, a leading provider of software solutions for FDA and GMP-compliant manufacturing, is…

4 months ago

HopeAI Showcases AI-Powered Synthetic Data to Speed Up Cancer Drug Trials at ASCO 2025

NEW YORK, Aug. 13, 2025 /PRNewswire/ -- HopeAI , a Mayo Clinic Platform Accelerate company, is advancing how cancer clinical…

4 months ago

A.D.A.M. Consumer Health Successfully Maintains URAC Certification; Reinforces Commitment to Quality and Excellence

JOHNS CREEK, Ga., Aug. 13, 2025 /PRNewswire/ -- A.D.A.M. Consumer Health (A.D.A.M.), part of the global Ebix Group, has successfully…

4 months ago

Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results

- Dermata announced additional positive data from its XYNGARI™ Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial-- Raised…

4 months ago

Onco-Innovations Announces Closing of Private Placement

Not for distribution to United States wire services or for dissemination in the United States VANCOUVER, BC / ACCESS Newswire…

4 months ago

Ensysce Biosciences Reports Second Quarter 2025 Financial Results and Latest Program Updates

Initiates Critical Milestone, Launching Phase 3 Trial of PF614 to Advance Next-Generation Opioid Therapy Toward Regulatory ApprovalReceives $5.3 Million Installment…

4 months ago